Fifteen-Year-Old Female With Delayed Progression of Puberty and Visual Disturbances

Abstract

Get full access to this article

View all access options for this article.

References

Vilar

Freitas

Naves

. Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest. 2008;31:436-444.

Shrivastava

Arginteanu

King

Post

. Giant prolactinomas: clinical management and long-term follow up. J Neurosurg. 2002;97:299-306.

Alexander Mann

. Treatment for prolactinomas and hyperprolactinoma: a lifetime approach. Eur J Clin Investig. 2010;41:334-342.

Melmed

Casanueva

Hoffman

. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:273-288.

Webster

Piscitelli

Polli

. Dose-dependent suppression of serum prolactin by cabergoline in hyperprolactinaemia: a placebo controlled, double blinded, multicenter study. European Multicenter Cabergoline Dose-finding Study Group. Clin Endocrinol (Oxf). 1992;37:534-541.

Colao

Di Sarno

Landi

. Macroproaclintoma shrinkage during cabergoline treatment is greater in naïve patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patients. J Clin Endocinol Metab. 2000;85:2247-2252.

Verhelst

Abs

Maiter

. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab. 1999;84:2518-2522.

Colao

Di Sarno

Sarnacchiaro

. Prolactinomas resistant to standard dopamine agonists respond to chronic cabergoline treatment. J Clin Endocrinol Metab. 1997;82:876-883.

Losa

Mortini

Barzaghi

Gioia

Giovanelli

. Surgical treatment of prolactin-secreting pituitary adenomas; early results and long-term outcome. J Clin Endocrinol Metab. 2002;87:3180-3186.